Fig. 1. Synthesis, formulation, and evaluation of PEG-bl-DEAEMA-co-BMA nanocarriers for cytosolic drug delivery. (A) Schematic of pH-responsive PEG-DB nanocarrier facilitated cytosolic drug delivery mechanism. (B) Schematic of FNP approach to formulate PEG-DB nanocarriers. (C) RAFT polymerization scheme used to synthesize PEG-bl-DEAEMA-co-BMA diblock copolymers with varying second-block molecular weight.
